Table 1.
Descriptive characteristics of participants across studies.
| Article | Population | Pathology type | Sample | Male/Female | Mean age ± SD | Range | Participant Characteristics | |
|---|---|---|---|---|---|---|---|---|
| Healthy subjects | Pathology | |||||||
| Buhmann et al., 2016a | X | N/A | 30 | 9/21 | 36.57 ± 14.94 | 17–77 | 66.67% musical education; 1/3: music while jogging | |
| Dickstein and Plax, 2012 | X | N/A | 10 | 0/10 | 24.2 | 22–29 | / | |
| Leow et al., 2014 | X | N/A | 43 | 19/24 | U | 18–20 | / | |
| Leow et al., 2015 | X | N/A | 11 | 5/6 | 22 | U | Music experience: 5.09 ± 6.02 years | |
| Marmelat et al., 2014 | X | N/A | Exp 1: 12Exp 2: 12 | Exp1: 5/7 Exp2: 7/5 | 28 ± 6 | U | / | |
| Mendonça et al., 2014 | X | N/A | 9 | 6/3 | 25 | U | / | |
| Roerdink et al., 2011 | X | N/A | 20 | 10/10 | 63.2 ± 3.6 | U | / | |
| Terrier and Deriaz, 2012 | X | N/A | 20 | 10/10 | 36 ± 11 | U | / | |
| Cha et al., 2014 | X | Stroke | 41 | 24/17 | 60.8 ± 19.8 | U | Onset in months: 6.68 ± 2.35; Able to walk 10 m independently; no hearing; visual deficits; MMSE ≥ 24; 19 R hemiparetic; 22 L hemiparetic | |
| Pelton et al., 2010 | X | Stroke | 8 | 5/3 | 70 ± 12 | 52–91 | Onset >6 months previously; Able to walk 10 m independently; MMSE >21; Average walking speed: 0.81 m/s (0.39); 4 R hemiparetic; 4 L hemiparetic | |
| Thaut et al., 1999 | X | Huntington's | 27 | 13/14 | 47 ± 10.7 | 31–68 | Mean duration of disease: 7 ± 3.3 years; Mean disability score: 1.28 ± 0.65 Mean chorea score: 1.37 ± 0.61 | |
| Roerdink et al., 2009 | X | X | Stroke | 11 | 7/4 | U | 42–71 | 8 R hemiparetic; 3 L hemiparetic; Able to walk 3 min without walking aid |
| Dotov et al., 2017 | X | X | Healthy subjects | 10 | 6/4 | U | 56–74 | / |
| Parkinson's | 19 | U | 37–78 | H&Y: median stage 2; Median disease duration: 6 years (range: 3–20) | ||||
| McIntosh et al., 1997 | X | X | Healthy subjects | 18 | U | 39–79 | / | |
| Parkinson's (ON) | 21 | 15/6 | 71 ± 4 | U | Mean disease duration: 7.5; H&Y II: 8; H&Y III: 10; H&Y IV: 3 | |||
| Parkinson's (Off) | 10 | 6/4 | 73 ± 3 | U | Mean disease duration: 7.8; H&Y II: 4; H&Y III: 6; H&Y IV: 1 | |||
| Hove et al., 2012 | X | X | Healthy subjects | 10 | 4/6 | 72 ± 5 | U | / |
| Parkinson's | 20 | 8/12 | 69.2 ± 7.7 | U | Mean duration disease: 3.6 years; H&Y: 2–3; ON medication | |||
| Nomura et al., 2012 | X | X | Healthy subjects | 18 | 16/2 | 24.7 ± 2.7 | U | / |
| Parkinson's | 20 | 8/12 | 69.2 ± 7.7 | U | Mean duration disease: 3.6 years; H&Y: 2–3; ON medication | |||
N/A, Not applicable; R, Right; L, Left; U, unknown; MMSE, Mini Mental State Examination; H&Y, Hoeln and Yahr; m, meters; m/s , meters/second.